These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 29564023)

  • 1. Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review.
    Draht MXG; Goudkade D; Koch A; Grabsch HI; Weijenberg MP; van Engeland M; Melotte V; Smits KM
    Clin Epigenetics; 2018; 10():35. PubMed ID: 29564023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review.
    de Ruijter TC; van der Heide F; Smits KM; Aarts MJ; van Engeland M; Heijnen VCG
    Breast Cancer Res; 2020 Jan; 22(1):13. PubMed ID: 32005275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic DNA methylation markers for renal cell carcinoma: a systematic review.
    Joosten SC; Deckers IA; Aarts MJ; Hoeben A; van Roermund JG; Smits KM; Melotte V; van Engeland M; Tjan-Heijnen VC
    Epigenomics; 2017 Sep; 9(9):1243-1257. PubMed ID: 28803494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal DNA methylation markers for detecting stages of colorectal cancer and its precursors: a systematic review.
    Raut JR; Guan Z; Schrotz-King P; Brenner H
    Clin Epigenetics; 2020 Aug; 12(1):122. PubMed ID: 32778176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenome-wide discovery and evaluation of leukocyte DNA methylation markers for the detection of colorectal cancer in a screening setting.
    Heiss JA; Brenner H
    Clin Epigenetics; 2017; 9():24. PubMed ID: 28270869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients.
    Draht MX; Smits KM; Tournier B; Jooste V; Chapusot C; Carvalho B; Cleven AH; Derks S; Wouters KA; Belt EJ; Stockmann HB; Bril H; Weijenberg MP; van den Brandt PA; de Bruïne AP; Herman JG; Meijer GA; Piard F; Melotte V; van Engeland M
    Mol Oncol; 2014 May; 8(3):679-88. PubMed ID: 24560444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome.
    Draht MX; Smits KM; Jooste V; Tournier B; Vervoort M; Ramaekers C; Chapusot C; Weijenberg MP; van Engeland M; Melotte V
    Clin Epigenetics; 2016; 8():44. PubMed ID: 27118999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different definitions of CpG island methylator phenotype and outcomes of colorectal cancer: a systematic review.
    Jia M; Gao X; Zhang Y; Hoffmeister M; Brenner H
    Clin Epigenetics; 2016; 8():25. PubMed ID: 26941852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer.
    Gyparaki MT; Basdra EK; Papavassiliou AG
    J Mol Med (Berl); 2013 Nov; 91(11):1249-56. PubMed ID: 24057814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of 3-CpG methylation prognostic signature based on different survival indicators for colorectal cancer.
    Huang H; Zhang L; Fu J; Tian T; Liu X; Liu Y; Sun H; Li D; Zhu L; Xu J; Zheng T; Jia C; Zhao Y
    Mol Carcinog; 2021 Jun; 60(6):403-412. PubMed ID: 33826760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation based biomarkers in colorectal cancer: A systematic review.
    Lam K; Pan K; Linnekamp JF; Medema JP; Kandimalla R
    Biochim Biophys Acta; 2016 Aug; 1866(1):106-20. PubMed ID: 27385266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review and REMARK scoring of renal cell carcinoma prognostic circulating biomarker manuscripts.
    Iafolla MAJ; Picardo S; Aung K; Hansen AR
    PLoS One; 2019; 14(10):e0222359. PubMed ID: 31639128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients Identified by Using a Genome-Wide High-Resolution Array.
    Lin PC; Lin JK; Lin CH; Lin HH; Yang SH; Jiang JK; Chen WS; Chou CC; Tsai SF; Chang SC
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1419-27. PubMed ID: 25472652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel CpG-methylation-based nomogram predicts survival in colorectal cancer.
    Wang X; Wang D; Liu J; Feng M; Wu X
    Epigenetics; 2020 Nov; 15(11):1213-1227. PubMed ID: 32396412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
    Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
    Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation profile in CpG-depleted regions uncovers a high-risk subtype of early-stage colorectal cancer.
    Yu H; Wang X; Bai L; Tang G; Carter KT; Cui J; Huang P; Liang L; Ding Y; Cai M; Huang M; Liu H; Cao G; Gallinger S; Pai RK; Buchanan DD; Win AK; Newcomb PA; Wang J; Grady WM; Luo Y
    J Natl Cancer Inst; 2023 Jan; 115(1):52-61. PubMed ID: 36171645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of methylation markers in colorectal cancer (Review).
    Kong C; Fu T
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34212989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reporting in studies of protein biomarkers of prognosis in colorectal cancer in relation to the REMARK guidelines.
    Jankova L; Dent OF; Molloy MP; Chan C; Chapuis PH; Howell VM; Clarke SJ
    Proteomics Clin Appl; 2015 Dec; 9(11-12):1078-86. PubMed ID: 25755195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant Methylation of FOXE1 Contributes to a Poor Prognosis for Patients with Colorectal Cancer.
    Sugimachi K; Matsumura T; Shimamura T; Hirata H; Uchi R; Ueda M; Sakimura S; Iguchi T; Eguchi H; Masuda T; Morita K; Takenaka K; Maehara Y; Mori M; Mimori K
    Ann Surg Oncol; 2016 Nov; 23(12):3948-3955. PubMed ID: 27271927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying CpG sites with different differential methylation frequencies in colorectal cancer tissues based on individualized differential methylation analysis.
    Yan H; He J; Guan Q; Cai H; Zhang L; Zheng W; Qi L; Zhang S; Liu H; Li H; Zhao W; Yang S; Guo Z
    Oncotarget; 2017 Jul; 8(29):47356-47364. PubMed ID: 28537885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.